• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Care for Patients with Stroke During the COVID-19 Pandemic: Physical Therapy and Rehabilitation Suggestions for Preventing Secondary Stroke
Infection with the novel severe acute respiratory syndrome coronavirus 2 causes the development of the novel 2019 coronavirus disease (COVID-19) and associated clinical symptoms, which typically presents as an upper respiratory syndrome such as pneumonia. Growing evidence indicates an increased prevalence of neurological involvement (e.g., in the form of stroke) during virus infection. COVID-19 has been suggested to be more than a lung infection because it affects the vasculature of the lungs and other organs and increases the risk of thrombosis.
Source: Journal of Stroke and Cerebrovascular Diseases - July 21, 2020 Category: Neurology Authors: Chien-Chih Wang, Jian-Kang Chao, Mong-Lien Wang, Yi-Ping Yang, Chien-Shiu Chien, Wei-Yi Lai, Yi-Chiang Yang, Yu-Hui Chang, Chen-Liang Chou, Chung-Lan Kao Source Type: research

Thalamic perforating artery stroke on computed tomography perfusion in a patient with coronavirus disease 2019
We present a case illustrating the value of CT perfusion to identify acute small subcortical infarcts in a patient with COVID-19 admitted to an intensive care unit for bilateral pneumonia and pulmonary embolism presenting with sudden right limb weakness.
Source: Journal of Stroke and Cerebrovascular Diseases - May 20, 2020 Category: Neurology Authors: Salvatore Rudilosso, Diana Esteller, Xabier Urra, Ángel Chamorro Tags: Case Report Source Type: research

Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 – Systematic Review, Meta-analysis, and Meta-regression
At the time of writing this paper, Coronavirus Disease 2019 (COVID-19) was announced as a global pandemic which has infected over 3.3 million people and cause more than 238.000 deaths,1 these numbers are likely to increase by the time of publication. Even though most of the infected individuals have mild or no symptoms, some of them exhibit more serious complications, including severe pneumonia, acute respiratory distress syndrome, and multi-organ failure. Clinical markers can be valuable for efficient allocation of resources during a pandemic.
Source: Journal of Stroke and Cerebrovascular Diseases - May 13, 2020 Category: Neurology Authors: Raymond Pranata, Ian Huang, Michael Anthonius Lim, Prof. Eka Julianta Wahjoepramono, Julius July Source Type: research

Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 –systematic review, meta-analysis, and meta-regression
At the time of writing this paper, Coronavirus Disease 2019 (COVID-19) was declared a global pandemic, which had infected over 3.3 million people and caused more than 238.000 deaths,1 These numbers are likely to increase by the time of publication. Even though most of the infected individuals have mild or no symptoms, some exhibit more serious complications including severe pneumonia, acute respiratory distress syndrome, and multi-organ failure. Clinical markers can be valuable for the efficient allocation of resources during the pandemic.
Source: Journal of Stroke and Cerebrovascular Diseases - May 13, 2020 Category: Neurology Authors: Raymond Pranata, Ian Huang, Michael Anthonius Lim, Eka Julianta Wahjoepramono, Julius July Source Type: research